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Cogito Ergo Sum 
These are the famous words of Rene Descartes, and roughly translate in English to ‘I think, 
therefore I am.’ The limit of scepticism is to doubt the existence of oneself. I am grateful to 
Rene Descartes who pointed out that the ability to think proves that one does exist. Consider 
this another way, it may be argued that one no longer ‘exists’ if one stops thinking.  So, it is 
important to keep thinking.  
I am grateful to my friend and my principal supervisor Ganesh Acharya who planted a seed in 
my mind that I should register for a doctorate at the University of Tromso. I still remember the 
day it happened: he had taken me for a long drive outside Tromso through the beautiful 
countryside of Northern Norway. It is then that he questioned my future plans. He was candid 
enough to make me realise that it is now or never. I am glad that he did that, for it made me 
think about my own future career direction. He tolerated my several visits to his home in 
Tromso, my demands on his precious time, my occupation of his office when I was there, 
several telephone calls, innumerable face-time calls and Skype conversations. He reassured me 
that this project is not only possible, but is worthwhile, despite the trips that I would have to 
make. Without his confidence in me, I would not have even begun, let alone completed the 
doctorate. What begun with a casual conversation in the Florence ISUOG congress grew into 
deep and trusting friendship, and I am very grateful for that. I am grateful to Larissa for 
welcoming both me and my wife in their home, and for tolerating our claim on Ganesh’s time.  
I am grateful to have Juha as my co-supervisor for this dissertation. It was with trepidations that 
I proposed to have my dissertation based on Juha’s sheep experiments. To my pleasant surprise 
I had his unconditional support. What started as a visit to the animal laboratory on Oulu for a 
couple of days out of curiosity, turned into a dissertation for a doctorate. He and his entire team 
made me feel very welcome, first as a visitor and later as a member of the team. He looked after 
me during all my visits starting from airport pick-ups and drops. I cannot forget the day-long 
drives he has made for me and Ganesh just so that our travelling is made easier. His attention 
to details, critical wise comments and constructive suggestions have significantly improved the 
manuscript versions I worked on towards submission. His wry sense of humour and undying 
optimism is second to none. It is indeed my privilege to work with Juha. Working with Juha, 
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Ganesh and the team does not remain work, but turns into an exciting expedition. There is time 
for enjoying as well, with visits to the best eating places in Oulu.  
I am grateful to the chief of the animal laboratory Hanna-Marja for allowing me to attend and 
also operate on animals in her lab. She and her entire team have been working quietly in the 
background, looking after the animals with great care and empathy. Without their support, the 
animal experiments would not have been possible. During this time, I gained several new 
friends: Tiina, Mervi, Kaarin, Aydin, Juulia, Heikki, Pasi, Olli, Veikko, Juha, Maria, 
Purusotam, Jonas, Magnus, Peter and Ase to name a few. Each one has been exceptionally 
warm, helpful and welcoming.  
Part of the research work was supported by a research grant from the regional health authority 
of Northern Norway. Without the financial support, this research work would not have been 
possible.  
I am very grateful to my family who have stood by me in this apparently crazy endeavour. They 
have tolerated my absences for the experiments and theoretical study component attendance. I 
have spent many weekend evenings analysing data, reading course material, writing 
manuscripts and dissertation and talking to Juha or Ganesh. I am grateful to them to have 
allowed me to pursue my dream.   
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The objectives were  
1. To study the effect of placental embolisation as well as maternal hypoxaemia on fetal left 
and right ventricular function as reflected by pulsed-wave Doppler-derived myocardial 
performance index (MPI). 
2. To study myocardial systolic and diastolic function of the fetal left and right ventricles using 
ultrasound speckle tracking technique to measure global strain and strain rate. 
3. To examine if fetal administration of Sildenafil can relieve reactive pulmonary vaso-
constriction in a hypoxaemic fetus.  
4. To assess the effects of Sildenafil on cardiac function. 
 
Methods  
We used pregnant sheep on gestational day 115-129/145 (approximately 4/5th of the length of 
gestation) for the study. Separate sets of experiments were performed for each component of 
the study described above. Pregnant sheep were operated under general anaesthesia in order to 
place measurement equipment in the ewe and the fetus. Catheters were placed in fetal carotid 
artery and jugular vein. An ultrasonic transit-time flow probe was placed around the ductus 
arteriosus to measure ductal blood flow. Electrodes were placed to obtain fetal ECG. A catheter 
was kept in the amniotic cavity to measure the amniotic fluid pressure. Experiments were 
performed after a recovery period of 48-72 hours.  Baseline measurements of fetal blood gases 
and acid-base status were performed. 
In the first set of the experiments, we studied the effect of both placental embolisation and fetal 
hypoxaemia (caused by maternal hypo-oxygenation) on fetal global cardiac function using 
ultrasound. We evaluated global myocardial function with pulse-wave Doppler-based 
myocardial performance index. Stored fetal myocardial tissue was subjected to hypoxic gene 
panel using polymerase chain reaction (PCR) to assess expression of hypoxaemic genes. 
In the second set of experiments we studied the changes in function of the fetal heart in response 
to hypoxaemia. An angle independent technique for assessing myocardial function (ultrasound 
speckle tracking) was used for this purpose. The evaluation of strain and strain rate was 
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performed off-line on stored loops of the ultrasound examinations carried out during the 
experiments. 
In the third set, fetal cardiac systolic function was evaluated using ventricular outputs, global 
longitudinal strain/strain rate with speckle tracking echocardiography and isovolumic 
contraction velocities of the ventricular wall at the level of the mitral and tricuspid valves with 
tissue Doppler. Diastolic function was evaluated using isovolumic relaxation velocities using 
tissue Doppler and pulsatility index of the ductus venosus with pulsed wave Doppler 
ultrasound. Pulmonary blood flow was calculated from the ductus arteriosus flow and left 
ventricular output. Pulsatility index of the right pulmonary artery was measured with pulsed 
wave Doppler ultrasound. The measurements were obtained at baseline, with hypoxaemia and 
at recovery. Animals administered saline or Sildenafil after hypoxemia was induced, and the 
two groups were used for comparison. 
Linear mixed model analysis was used to analyse data on repeated measurements taking into 
account correlation of measurements carried out in an individual fetus at different time-points. 
Random intercept model was selected. 
 
Results  
Placental vascular resistance and umbilical artery PI increased significantly with placental 
embolization. During hypoxaemia, mean LV MPI increased significantly only in fetuses with 
an intact placenta, returning to baseline during the recovery phase. Right ventricular MPI was 
unaffected. Expression of the hypoxaemic genes was no different with or without placental 
embolisation. Significantly lower expression of genes involved in cardiac contractile function 
and its regulation were seen in the group with placental embolisation.  
Using speckle tracking echocardiography, baseline mean (SD) left and right ventricular global 
longitudinal strains were -18.7% (3.8) and -14.3% (5.3) respectively (p = 0.003). Hypoxaemia 
at 30 and 120 minutes led to a significant reduction (less deformation) in the global longitudinal 
strain of the LV, while the global circumferential and radial strains were not affected by fetal 
hypoxaemia. During the recovery period, LV global longitudinal strain returned back to 
baseline level. Right ventricular global longitudinal, circumferential or radial strains did not 
change significantly.  
In the third set of experiments, fetal hypoxaemia did not affect RVCO that remained unchanged 
in both groups. However, LVCO and combined cardiac output fell significantly in both the 
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groups during hypoxaemia and remained significantly lower in recovery phase than at baseline. 
In both groups, lung volume blood flow decreased and flow across the ductus arteriosus 
increased significantly during hypoxaemia phases with no difference between the Sildenafil 
and control groups. During hypoxaemia phases left but not right ventricular global longitudinal 
deformation was reduced (p = 0.003) in both groups. Both right and left ventricular and 
isovolumic relaxation velocity (IVRV) decreased significantly during hypoxaemia phases with 
no apparent effect of Sildenafil. Fetal hypoxaemia led to pulmonary arterial vasoconstriction, 
decreased lung volume blood flow, increased shunting through the ductus arteriosus, reduced 




In near-term sheep fetus, fetal left ventricle is more sensitive to acute hypoxaemia than the right 
ventricle. LV global longitudinal and circumferential deformations are greater as compared to 
RV. Acute hypoxaemia leads to LV rather than RV dysfunction as demonstrated by decreased 
deformation. Direct administration of Sildenafil to hypoxic fetuses did not reverse 






The history of evolution is fascinating. Geochemical models suggest a marked increase, and 
then a decline in atmospheric oxygen levels. The extent of the increase is debated, but may have 
reached 35% compared to the current 21%. Blue-green algae (Cyanobacteria), in a phenomenon 
known as the great oxygenation event or oxygen catastrophe are thought to be responsible for 
the oxygen peak, approximately 3.2 billion years ago(1). The fluctuations of the atmospheric 
O2 have influenced evolution of life on earth. Complex multicellular organisms evolved, and 
the greatest challenge to aerobic organisms became oxygen deprivation. The first physiological 
system to become functional during mammalian development is the circulatory system. 
Circulation must be established once the embryo becomes too large for O2 to be delivered 
simply by diffusion. 
 
Several compensatory or defence mechanisms evolved to protect from hypoxemia. Nowhere 
else are these mechanisms more important than the fetal life. The fetus not only survives, but 
also grows in conditions with significantly lower oxygen concentrations as compared to adults. 
How organisms distribute and utilise 02 under normoxaemic as well as hypoxaemic conditions 
has been the subject of research for many scientists(2). Oxygen deprivation can be experienced 
by the fetus in the prenatal period due to compromised delivery such as high altitude or maternal 
anaemia or abnormal placentation. In the intrapartum period, the uterine contractions lead to a 
hypoxic challenge. Reduction in the blood flow in the maternal intervillous space and/or 
compression of the umbilical cord can lead to fetal hypoxia. Although most fetuses are able to 
adapt to and withstand some degree of hypoxic challenge, not all can. Early identification of 
compromised fetuses is the focus of research into antepartum as well as intrapartum assessment 
of fetal wellbeing. Fetal circulation is unique, in that the two ventricles work in parallel before 
birth rather than in series after birth (also see later). There are three sites where shunting occurs 
in the fetus: a) Ductus venosus where the oxygenated venous blood bypasses the liver, b) 
Foramen ovale, where umbilical venous blood bypasses the lungs and c) Ductus arteriosus 
where arterial blood bypasses the lungs. All these three shunts close at, or soon after birth. 
Accurate knowledge of fetal circulation is necessary to understand fetal responses to 




3 Cellular effects of hypoxaemia 
Adenosine triphosphate (ATP) is the energy currency of the body, and is the essential link 
between energy utilisation and energy production. Availability of oxygen is necessary for the 
maintenance of oxidative phosphorylation leading to energy transfer. Cells have to switch to 
anaerobic metabolism with lack of oxygen. Anaerobic metabolism is relatively inefficient. One 
mole of Glucose produces 38 moles of ATP in theory, but 30-32 moles in real life with oxidative 
metabolism(3).  This represents 66% of the total energy stored in a Glucose molecule. In 
contrast, anaerobic metabolism involves breakdown of one molecule of Glucose into Pyruvate 
and NADH, with formation of 2 ATPs (just over 3% of total energy in a glucose molecule). 
The resultant Pyruvate and NADH combine to form lactic acid. Thus, lack of oxygen leads to 
a build-up of lactic acid (metabolic acidosis).  
Oxygen must reach the fetus across the placenta. In the fetal sheep, placental utilisation is 40% 
of the total uterine oxygen uptake, the remaining being delivered to the fetus. Bonds et al(4) 
showed that in human pregnancies, placental oxygen consumption is 0.58 mM/min, whereas 
fetal oxygen consumption was 0.98 mM/min. Thus, placental oxygen consumption is 40% of 
the total oxygen consumed even in the human pregnancy. The placenta is metabolically much 
more active (per unit mass of tissue) as compared to the fetus. Factors that determine oxygen 
transfer to the fetus are affinity and oxygen capacity (Hb concentration) in maternal and fetal 
blood, blood-flow to the placenta, permeability of trophoblast cells intervening the two 
circulations, the total surface area available for transfer and oxygen consumption by the 
placenta(3). In human pregnancies, assuming uterine blood flow of 750 ml/min and maternal 
Hb of 120 g/L, the O2 delivery can be calculated to be 5.7mM/min at term. Oxygen uptake of 
the normally grown human fetus at term is approximately 6.6 ml/kg/min (0.3 mM/kg/min), and 
is not significantly affected by normal labour and delivery(5). Fetal oxygen consumption can 
largely be maintained in spite of fluctuations in oxygen delivery. Thus, fetal and maternal 
placental blood flows and blood oxygen capacities can be altered by as much as 50 % without 
any major change in fetal oxygen uptake. However, there is a critical threshold below which 
fetal oxygen uptake becomes dependent on oxygen delivery. In the sheep this corresponds to 




4 Hypoxaemia and alteration of genes 
Response to hypoxaemia is characterised by altered expression of several genes. Hypoxia-
inducible factor 1 (HIF-1) functions as a master regulator of oxygen homeostasis by controlling 
both the delivery and utilization of O2(6). HIF-1 activity is induced by hypoxia through changes 
in HIF-1α mRNA and protein levels in the heart amongst other tissues. HIF-1 directly regulates 
the expression of more than 1,000 human genes(6). HIF-1 regulates vascular responses to 
hypoxia and ischemia. HIF-1 activates the transcription of multiple genes encoding angiogenic 
growth factors and cytokines. This effect can be studied, thanks to the availability of modern 
laboratory techniques such as PCR and Western blotting (please also see Table 1 in Appendix). 










ANP	 Atrial	natriuretic	peptide	 Vasodilator,	 reduces	 the	 water	 and	 sodium	
loads	on	the	circulatory	system(8)	
BNP	 Brain	natriuretic	peptide	 Similar	to	ANP(8)	







Involved	 in	 regulation	 of	 the	
contraction/relaxation	cycle(10)	
STAT3	 Signal	 transducer	 and	
activator	of	transcription-3	







5 Fetal cardiovascular system and Hypoxaemia 
Several organ systems show adaptive changes to the lack of oxygen. The fetal cardiovascular 
system is perhaps the most dynamic system when adaptation to hypoxaemia is concerned. There 
are several differences between the adult and the fetal circulation. These differences mean that 
application of concepts derived from adult cardiology cannot be directly applied to fetal 
circulation. Many non-invasive parameters used in cardiology remain unvalidated in the fetus. 
Prenatally detected structural defects can be verified after birth. However, functional alterations 
cannot be ascertained after birth, because neonatal circulation is considerably different from 
the fetal circulation. Therefore, study of the function of the fetal heart and the circulation 
remains difficult. A thorough understanding of these differences is important before adaptations 
to hypoxia can be studied.  
 
The main function of the heart is to deliver sufficient oxygenated blood to meet the metabolic 
requirements of the tissues(13). The overall performance is dependent on a complex interplay 
between the heart, blood volume and the vasculature.  
5.1 The	fetal	circulation	
Fetal circulation differs considerably as compared to adult. Placenta is an organ functional 
exclusively before birth, and receives 40% of the combined cardiac output in the sheep 
fetus(14). In human fetus, the proportion is lower(15). The right and the left ventricles pump in 
parallel in the fetus as opposed to in series in neonates. Oxygenated blood returning from the 
placenta is mixed with de-oxygenated blood. Three sites of mixing exist in the fetal circulation: 
the ductus venosus (umbilical vein to right atrium), foramen ovale (right and left atrium) and 
the ductus arteriosus (right ventricular outflow to aorta).  
The human fetal blood volume is 10-12% of the body weight compared to 7 to 8% in adults(16). 
At mid-gestation, as much as 50% of the total fetal blood volume may be contained within the 
placenta, but the fraction is reduced to 20 to 25% at term in fetal sheep(15). In humans, the 
fraction is 33% at birth(17). 
Placental vasculature is thought to account for 55% of the umbilical resistance(18). One must 
keep in mind the difference between resistance and impedance. Ultrasound Doppler technology 
is used to measure pulsatility index, which is a measure of vascular impedance. It has been 
shown that the infusion of vasopressor angiotensin-II to fetal sheep led to extreme 
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vasoconstriction, and 13-fold increase in umbilical arterial resistance(19). However, in another 
experiment, infusion of Angiotension II to fetal sheep did not change the pulsatility index of 
the umbilical artery(20). Therefore, one can conclude that increase in the resistance does not 
necessarily increase the pulsatility index.  
Placental vasculature has no neural regulation. It has been shown that the placental blood flow 
is not under auto-regulatory control(21). Nor-adrenaline and Angiotensin II both lead to 
vasoconstriction in the placental vasculature, but the site of their major action is different(19). 
None lead to an appreciable increase in resistance in the cotyledons. Placental blood flow is 
maintained with infusion of Noradrenaline, but is significantly reduced with Angiotensin(19).  
Prostanoids and endothelin lead to vasoconstriction of the placental vasculature, and NO to 
vasodilatation. However, the exact role of hormonal regulation of placental vasculature is not 
fully understood(22). Placental vascular resistance progressively decreases with advancing 
gestation due to extensive development of vascularisation in the placenta.  
 
5.2 Factors	affecting	fetal	cardiac	function	
Fetal heart rate – Provided that stroke volume is unaltered, an increase in the heart rate 
increases the cardiac output. Indeed, an increase in the heart rate is an important physiological 
mechanism to increase the cardiac output in adults in conditions needing an increase such as 
exercise. Relatively high fetal heart rate is responsible, in part, for higher weight-indexed 
cardiac output in comparison to the adult. However, rapid pacing of the fetal heart decreases 
stroke volume as filling time decreases(23, 24). Increase in the heart rate is tolerated poorly by 
the fetal heart, and the extent to which cardiac output can be increased by increasing fetal heart 
rate is limited. It is interesting that the cardiac output is unchanged across a wide range of 
baseline heart rate. In the human fetus, it is only with significant reduction (below 55 BPM) or 
increase (above 210-220 BPM) of fetal heart rate that fetal cardiac failure leading to fetal 
hydrops is observed(25, 26).   
Myocardial contractility - Contractility of the heart is the ability of the myocardium to generate 
a certain amount of pressure at a fixed volume. Cardiac excitation-contraction coupling is the 
process from electrical excitation of the cardiomyocyte to mechanical contraction of the cell. 
The second messenger Ca2+ is essential in cardiac electrical activity and is also the activator of 
the myofilaments which cause contraction. Ca2+ enters the cell through depolarization-activated 
Ca2+ channels during cardiac action potential. Ca2+ entry triggers Ca2+ release from the 
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sarcoplasmic reticulum (SR). The combination of influx of Ca2+ from outside the cell and 
release of intracellular Ca2+ allows it to bind to the myofilament protein troponin C. This 
process switches on the contractile machinery of the cell. For relaxation to occur intracellular 
free Ca2+ must decline, allowing Ca2+ to dissociate from troponin. This requires calcium 
transport out of the cytosol (back into the SR), and is a process requiring energy. It is the free 
intracellular calcium that is responsible for contraction. Calcium is present in the bound form 
(to SR), and the ratio of bound to free Ca2+ (100:1) suggests powerful buffering(10).  
There are two main ways to change the strength of cardiac contraction: by altering the amplitude 
or duration of the Ca2+ transient, and by altering the sensitivity of the myofilaments to Ca2+(10). 
Myocardial sensitivity can be increased by stretching (Frank-Starling mechanism), Caffeine 
and certain ionotropic drugs. Sensitivity is reduced by acidosis, hypoxia and beta-adrenergic 
activation. Although beta adrenergic stimulation reduces myocardial sensitivity (by 
phosphorylation of Troponin I), overall effect is increased contraction force brought about by 
higher sarcoplasmic Ca2+, and enhanced relaxation (lusitropy) by accelerated decline of free 
cytosolic Ca2+(10).  
Pre-load - Preload is the force per unit cross-sectional area of the ventricular wall just before 
contraction. In other words, it is the pre-contraction stretching of the chamber (end-diastolic 
volume). It is dependent on the blood volume, venous return and atrial contraction. Left and 
right fetal atrial pressures are equal(27). Increase in the pre-load has a limited ability to increase 
the cardiac output. Fetal left and right ventricles appear to be operating at the top of pre-load-
output curve(27, 28) and do not tolerate volume overload well. Fetal myocardium is known to 
be less compliant than the adult(29), so that high filling pressure has a limited impact on 
increasing end-diastolic volume. Moreover, ventricular filling is more dependent on atrial 
contraction than venous return in the fetus as compared to adults.  
Afterload - By definition, afterload is the load which an isolated muscle fibre has to overcome 
in order to shorten(30). The afterload is best defined as ventricular wall stress during ejection 
according to La Place’s law: Wall stress = PR/2h, where P is intra-cavitary pressure, R is radius 
of the curvature, and h is the thickness of ventricular wall. Oxygen consumption is a function 
of the tension that is developed and the velocity of shortening of the unloaded muscle(31). 
Afterload is mainly reflected by peripheral vascular resistance and arterial impedance. In the 
intact heart, it is correlated to the arterial pressure, which the ventricles have to overcome, in 
order to eject blood. The impedance to right ventricular emptying is contributed by resistance 
in the pulmonary circulation as well as descending aorta supplying the lower body and the 
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placenta via the ductus arteriosus. Impedance to the left ventricular emptying is contributed by 
resistance in cerebral circulation and the upper body. In the lamb fetus, increase in right 
ventricular afterload was associated with maintained right ventricular stroke volume and 
cardiac output(32). The ventricular volume was unchanged. Similarly, fetuses with increased 
placental vascular resistance are able to maintain their cardiac output(33, 34), although left 
ventricle contributes a higher proportion(35). The afterload (arterial pressure) for fetal left and 
the right ventricles should be equal, since they pump in parallel. The function of the two 
ventricles is closely dependent on each other. They share common muscular fibres encircling 
the chambers. Shunting at the level of foramen ovale allows equalisation of filing pressure 
(preload). Moreover, presence of the ductus arteriosus leads to equalisation of the afterload.  
Neuro-hormonal influences - The fetal heart responds to hypoxia with an acute reduction in the 
heart rate and hypertension(36). This response is abolished by denervation of the carotid sinus. 
Variability of the baseline heart rate is reduced following chemical sympathectomy. However, 
sympathectomy did not alter fetal heart variability between episodes of umbilical cord 
occlusion, suggesting that this might be under hormonal rather than neural influence(37).  
Growth and development -  The fetal myocardium is much stiffer (less compliant) as compared 
to neonates(29). In fact, the compliance progressively increases with advancing gestation. This 




The normal cardiac cycle has five phases from end-systole to the next end-systole.  
1. Isovolumetric	relaxation	phase	–	This	 is	the	 interval	between	the	end	of	ventricular	
contraction,	when	the	myocardial	fibres	begin	to	relax	identified	by	closure	of	the	semilunar	
valves	 to	 the	 beginning	 of	 ventricular	 filling	 identified	 by	 opening	 of	 the	 A-V	 valves.	 The	
volume	of	the	ventricular	contents	is	constant.		
2. Early	 diastolic	 filling	 –	 This	 begins	 with	 the	 opening	 of	 the	 A-V	 valves.	 The	 atrial	




Active	 ventricular	 relaxation	 continues	 in	 this	 phase,	 and	 is	 responsible	 for	 filling	 of	 the	
chamber.	
3. Late	 diastolic	 filling	 –	 This	 is	 due	 to	 atrial	 contraction,	 and	 gives	 the	 last	 ‘kick’	 to	
complete	ventricular	filling	before	the	onset	of	ventricular	contraction.	
4. Isovolumetric	contraction	phase	–	This	is	the	interval	between	closure	of	the	A-V	valves	
when	 rising	 intraventricular	 pressure	 exceeds	 the	 atrial	 pressure	 and	 the	 opening	 of	 the	
semilunar	valves	when	the	rising	intraventricular	pressure	surpasses	that	in	the	aorta	and	the	
pulmonary	artery.		
5. Ejection	phase	–	This	 is	 the	phase	when	the	 intraventricular	blood	 is	ejected	 in	 the	
great	arteries.		
These main components of the cardiac cycle define the main features of cardiac blood flow 
movement and myocardial motion and deformation. Heart failure is defined as a complex 
clinical syndrome that can result from any structural or functional cardiac disorder that impairs 




6 Assessment of fetal cardiac function using ultrasound 
Hypoxaemia is a condition characterised by a reduction in the amount of oxygen carried by the 
blood. The fetus responds to hypoxic stress in a variety of ways. Heart is an essential organ, 
and vulnerable to the effect of hypoxaemia. There are several ways to study the function of the 
fetal heart in the presence of hypoxaemia. Ultrasound is non-invasive, and is extensively used 
for prenatal evaluation of the human fetus.  
 
Current techniques of evaluation of fetal heart function using ultrasound can be divided into the 
following(30, 40, 41):  
 
M-mode based techniques  
 
6.1 Fractional	shortening	(FS)	and	ejection	fraction	(EF)	
Ventricular end-systolic diameter (ESD) and end-diastolic diameter (EDD) are both obtained 
from two-dimensional M-mode images in a four-chamber view with the cursor perpendicular 
to the interventricular septum, just below the tip of the mitral valve leaflets(42).  Maximal and 
minimal distances between the endocardium of the right ventricular anterior wall and the 
interventricular septum are measured with M-mode imaging. These distances are used to 
calculate the maximal end-diastolic dimension and minimal end-systolic dimension of the right 
ventricle, respectively. Similarly, the maximal and minimum distances between the 
endocardium of the left ventricular posterior wall and interventricular septum are used to 
calculate the EDD and ESD of the left ventricle (Figure 6-1).  
The ventricular FS and EF are derived from the end-diastolic (EDD) and end-systolic (ESD) 
diameters as follows:  
FS = (EDD-ESD)/EDD 







Figure 6-1 M-mode recording of a fetal heart at 24 weeks’ gestation demonstrating the 
measurements of ventricular dimensions 
RVAW	=	right	ventricular	anterior	wall,	RV	=	end-diastolic	dimension	of	the	right	ventricular	
cavity,	 IVS	=	 interventricular	septum,	LV	=	end-diastolic	dimension	of	 the	 left	ventricular	





Hsieh et al (42) reported that LV FS as well as EF remained unchanged from 10 till 40 weeks. 
RV FS and EF showed a gradual decline during this period (0.86 to 0.78 for EF, and 0.49 to 
0.42 for FS). Normal fractional shortening should be > 0.28(30) 
 
6.2 Tricuspid	or	mitral	annular	peak	systolic	excursion	(TAPSE/MAPSE)	
M-mode can be used to the movement of the atrio-ventricular annulus. This moves during the 
cardiac cycle. The peak systolic excursion of the mitral or tricuspid valve annulus during systole 
has been termed as MAPSE and TAPSE respectively (Figure 6-2). The annular displacement 
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can also be measured using other techniques such as colour or pulsed-wave TDI and two-
dimensional speckle tracking echocardiography(30).  
 
	




Techniques based on conventional pulsed-wave Doppler 
 
6.3 E/A	ratio		
Doppler assessment of the flow across atrio-ventricular valves is characterised by two peaks. 
The first peak is generated by the first rapid filling (E wave), and the second by the atrial 
contraction or ‘kick’ (A wave). The ratio of the amplitudes of the E and A waves generates E/A 
ratio (Figure 6-3). This ratio is independent of the angle of insonation, and can be used to assess 
fetal heart function(40). Pulse wave Doppler (PD) is used to measure the velocities by placing 






Figure 6-3 Pulse wave Doppler image showing the spectral Doppler waveform used for 
the calculation of the E/A ratio 
 
6.4 Left	and	right	ventricular	output	
Ventricular output can be measured with the use of grey scale and pulsed Doppler ultrasound. 
The diameters of the aortic and pulmonary valves are measured from frozen real-time images 
during systole by using the leading edge–to–leading edge method. cross sectional area of the 
vessel (A) is calculated with the assumption of a circular cross section. Blood velocity 
waveforms are obtained from the aortic and pulmonary valves using pulsed-wave Doppler. 
FHR (in beats per minute) is measured from the Doppler tracing, and the time-velocity integral 
TVI (in centimetres) is calculated by integrating the area underneath the Doppler spectrum. 
Volumetric blood flow (Q; in ml/minute) is calculated with the formula: Q=FHR×A×TVI. Left 
ventricular output (LVCO) equals the blood flow through the aortic valve and right ventricular 
output (RVCO) equals the blood flow through the pulmonary valve. Combined cardiac output 
(CCO) equals the sum of LVCO and RVCO.  
 
6.5 Myocardial	performance	index	for	assessing	global	cardiac	function		
Myocardial performance index (MPI, also known as Tei index) was originally described to 
evaluate dilated cardiomyopathy(43). It is defined as the ratio between the sum of the duration 





(Figure 6-4). Traditionally, this index has been calculated from the pulsed-wave Doppler (PD) 
recordings of ventricular inflow and outflow blood velocity waveforms. (please see the section 
on cardiac cycle). Within the index, the ICT and IRT reflect systolic and diastolic cardiac 
function respectively. The technique was refined by Hernandez-Andrade et al(44). They used 
the opening ‘clicks’ of the A-V valves to mark the timings, and showed that this technique was 
associated with a lower variation and better inter- and intra-observer agreement than the 






Figure 6-4 Tei index (MPI) evaluation using pulsed Doppler ultrasound. 







To calculate the LV Tei index (MPI), pulsed-wave Doppler (PD) blood velocity waveforms are 
obtained simultaneously from the inflow and outflow of the left ventricle, and measurements 
of ICT, IRT and ET can be made from the same cardiac cycle. However, this technique is not 
applicable for the right ventricle. Simultaneous blood flow velocity waveforms of the right 
ventricular inflow and outflow cannot easily be obtained because of the anatomical relationship 
of the right ventricle and its outflow tracts. Therefore, measurements of the components ‘a’ and 
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‘b’ of the cardiac cycle from the PD blood velocity waveforms of the RV inflow and outflow 
need to be obtained one after another from separate cardiac cycles (Figure 6-5). Consequently, 
measurement of the individual duration of RV ICT and IRT is not possible using PD.  
 
	
Figure 6-5 Right ventricular Tei index measurement using pulsed-wave Doppler-derived 
blood flow velocity waveforms obtained from the pulmonary and tricuspid valves in series. 
a	 =	 time	 interval	 from	 closure	 to	 opening	 of	 the	 tricuspid	 valve;	 b	 =	 time	 interval	 from	
opening	to	closure	of	the	pulmonary	valve	(ejection	time);	Tei	index	=	(a	−	b)/b.	
Acharya	 G	 et	 al,	 Ultrasound	 Obstet	 Gynecol	 2008;	 31:	 406–411	 (Reproduced	 with	
permission	from	the	publishers).	
	
MPI has been shown to reflect left and right ventricular function in adults, children and 
neonates. It combines systolic and diastolic function. Initial reports showed that it is 
independent of age, geometric assumptions, heart rate (HR), and blood pressure (BP)(45). This 
is not completely true though, and the MPI is influenced by loading conditions. Eidem et al(46) 
reported that left and right ventricular PD MPIs were no different in fetal life, and the indices 
were not significantly different from those observed in children between the age of  3 and 18 
 
30 
years. There was no significant change with gestational age. Similar findings have been 
reported by other groups(47).  
 
Van Mieghem et al(48) validated left ventricular MPI against E/A ratio (diastolic function) and 
ejection fraction (EF, for systolic function) in normal fetuses as well as fetuses with twin to 
twin transfusion syndrome (TTTS).  They reported an inverse correlation between MPI and EF 
(Spearman’s rho = -0.43, p<0.001), but not with the observed/expected E/A index (P = 0.56).  
  
Tei index has been studied as a possible marker of fetal heart dysfunction(49). However, the 
fetal circulation is quite different from adult circulation. Adult systemic and pulmonary 
circulations are connected in series, as opposed to being connected in parallel in the fetus. The 
dominant ventricle in adult life is the left ventricle. In fetal circulation, it is the right ventricle, 
which supplies blood to most of the body and the placenta. The fetal left ventricle preferentially 
perfuses the brain. In the setting of increased placental resistance, the afterload on the right 
ventricle is high. The resistance in the cerebral circulation, however, remains relatively low. 
The MPI has been reported to be increased in placental insufficiency, however it is uncertain 
whether it is a reflection of altered fetal cardiac loading condition or hypoxaemia. There have 
been a few previous attempts to study the relationship between hypoxaemia and MPI. One such 
study(50) reported elevated left as well as right ventricular MPI in hypoxia caused by acute 
cord occlusion. The effect of pure hypoxia (without an increase in the afterload) and the effect 
of non-acute elevation of placental resistance on fetal MPI have not been studied in 
experimental setting.  
 
Techniques based on tissue Doppler 
 
6.6 Tissue-Doppler	imaging	based	MPI		
Pulsed-tissue Doppler recordings of longitudinal myocardial wall motion are obtained at the 
level of mitral and tricuspid valve annuli in an apical four-chamber view for the calculation of 
the tissue Doppler (TD) MPI. For both ventricles, the ‘a’ component is measured as the time 
interval from the end of the myocardial lengthening velocity waveform during the late 
ventricular filling (atrial contraction) phase of diastole (A’) to the beginning of the myocardial 
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lengthening velocity waveform during early ventricular filling (E’). The waves of isovolumic 
myocardial contraction velocity(IVCV) and relaxation velocity(IVRV) are included in this 
measurement. The ‘b’ component is the time interval from the beginning (excluding IVCV) to 
the end of the myocardial shortening velocity waveform (S’) during the ventricular systole of 
the same cardiac cycle (Figure 6-6). The IRT is measured from the end of the S’ wave to the 
start of the E’ wave. The advantage of TD MPI is that simultaneous recordings of isovolumic 
contraction time, relaxation time and ejection time is possible in the same cardiac cycle for both 
ventricles. Moreover, individual measurements of ICT and IRT for the right ventricle is possible 






Figure 6-6 Right ventricular Tei index measurement using tissue Doppler-derived 
longitudinal myocardial wall motion velocities obtained at the tricuspid annulus. 
A’=	myocardial	 lengthening	velocity	during	 the	 late	ventricular	 filling	 (atrial	 contraction)	
phase	of	diastole;	a	=	time	interval	from	the	end	of	the	A’	wave	to	the	beginning	of	the	E’	
wave;	 b	 =	 time	 interval	 from	 the	 beginning	 to	 the	 end	 of	 the	 S’	wave;	 E’	 =	myocardial	
lengthening	velocity	during	early	ventricular	filling;	ICT	=	isovolumic	contraction	time;	IRT	=	
isovolumic	 relaxation	 time;	 IVCV	 =	 isovolumic	 myocardial	 contraction	 velocity;	 IVRV	 =	
isovolumic	 myocardial	 relaxation	 velocity;	 S’	 =	 myocardial	 shortening	 velocity	 during	
ventricular	systole;	Tei	index	=	(a	−	b)/b.	
Acharya	G	 et	 al,	 J	 Pregnancy.	 2011;2011:634240.	 (Open	 access	 resource.	 Permission	 to	
reproduce	not	required).	
	
A comparison of PD MPI and TD MPI in the fetal heart showed that there is significant bias(51). 
The TD MPI is much larger as compared to PD MPI in the same individual. The most likely 
reason for the difference is because the myocardial tissue begins movement before there is 
blood flow. Tissue Doppler detects movement of the tissue, whereas pulsed wave Doppler 
detects blood flow. The authors reported significant correlation between PD MPI and TD MPI 
of right, but not the left ventricle. Correlation between MPI measured by PD and TD methods 
was weak and the agreement between individual measurements was poor. Therefore, the 
authors reported that PD and TD techniques cannot be used interchangeably to measure fetal 
 
33 
MPI. Reproducibility was comparable for both techniques with the intra-class correlation 
coefficients (ICCs) close to 0.9 for both techniques and both ventricles. These findings are 
different from those reported by Comas et al(49). Although they did not directly study the 
agreement between PD MPI and TD MPI, their mean MPIs with either technique in the IUGR 
as well as control fetuses were very similar.  
 
6.7 Mitral	and	Tricuspid	isovolumic	acceleration	and	deceleration	velocities	
Despite reduced myocardial contractility, global cardiac function as measured by stroke volume 
and cardiac output are maintained with progressive hypoxaemia and metabolic acidosis(52). 
Isovolumic velocities of the mitral and tricuspid valve (See Figure 6-6) are sensitive indicators 
of myocardial dysfunction in response to hypoxaemia and metabolic acidosis(53, 54). These 
are independent of loading conditions and can be used non-invasively to measure myocardial 
force-frequency relationships(53).  
 
6.8 Ultrasound	speckle	tracking	
Conventional and tissue Doppler-based techniques are dependent on the angle of insonation, 
since the Doppler shift is sensitive to the angle. Angles lesser than 300 are recommended for 
reliable acquisition of data. Beyond angles of 600, the acquisition becomes unreliable. 
Ultrasound speckle tracking was developed in order to circumvent the problem of angle 
dependence. The use of speckle-tracking is an approach to study myocardial motion as a 
surrogate for cardiac function. It uses 2D B-mode echocardiography, and is based on 
identification of ‘speckles’(55). Speckles are natural acoustic markers, spread randomly 
throughout the myocardium, which are generated by stable interference and back-scatter of the 
ultrasound signal. Distinctive speckles are identified in consecutive frames of a cine-loop. With 
a known frame rate, the movement and velocity vector of each speckle can be calculated. 
Eventually, the strain and strain rate of the chamber can be evaluated segmentally as well as 
globally. Speckle tracking is usually coupled with an automated border recognition program, 
so that speckle tracking occurs within the context of the ventricle under investigation. Speckle 
tracking essentially measures myocardial deformation (change of shape). Changes in strain rate 
may be able to identify subtle changes in cardiac function not large enough to affect the 
traditional measures such as the ejection fraction. Speckle tracking has not yet been studied 
sufficiently for use in evaluation of diastolic function(40). The advantage of speckle tracking 
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over conventional 2-D ultrasound techniques is that it is more sensitive(56). Another advantage 
over pulsed wave and tissue Doppler is that it is relatively angle independent. 
Studies in adult humans have shown that exposure to normobaric hypoxia leads to an increase 
of regional myocardial deformation in both ventricles. The contractile reserve during hypoxic 
exercise is reduced in the left, but not the right ventricle(57).  
 
	










Figure 6-8 Assessment of left ventricular global circumferential strain using Speckle 
tracking echocardiography 





Koga et al(58) reported that isovolumic contraction time (ICT) increased in pregnancies 
complicated by placental insufficiency, and the prolongation of ICT predicted adverse effects. 
This investigation used conventional pulsed-wave Doppler ultrasound. Tissue Doppler Imaging 
(TDI) provides information on mechanical events of the myocardium as opposed to spectral 
Doppler providing information on flow. The duration of each of these events can be measured 
using TDI. Wagstrom et al(59) showed that there is relative prolongation of the pre-ejection 
(mean 50%) and post-ejection (mean 38%) intervals in lambs subjected to progressive umbilical 
cord occlusion leading to severe hypoxia and lactic acidosis. The left ventricle and the septum 
showed the most pronounced differences. The right ventricle exhibited less change in the pre-
ejection phase. One of the limitation of this experiment was that hypoxia was produced by 
occlusion of the umbilical cord. This would inevitably lead to varying venous return to the 
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heart, and also a change the afterload. Hypoxia caused by occlusion of the umbilical cord does 
not resemble the pathophysiology of fetal hypoxaemia resulting from placental insufficiency.  
 
Techniques used to study cardiac function are described in the table below:  
 
Table 2. Most commonly used parameters to assess fetal cardiac function (Modified from 


































7 Study of fetal Hypoxaemia 
7.1 Choice	of	the	animal	for	the	experimental	model	to	study	fetal	Hypoxaemia	
There is a long tradition for the use of sheep as experimental models for perinatal research. The 
ewe is similar in size to the human mother. In contrast to many small/medium animals such as 
rat, mouse or guinea pig, sheep pregnancies can be limited to a single fetus. The size of the 
sheep fetus at birth is comparable to that of the human fetus. Moreover, sheep have a relatively 
long gestation and similar ontogeny for all major organ systems.  Maternal and fetal blood 
vessels can be catheterized to directly measure blood gases, nutrient uptakes and metabolism 
in utero. Structure of the fetal heart and fetal circulation is essentially the same as that of human 
pregnancies. Another reason why sheep model is preferred is because preterm labour is 
uncommon even after surgical manipulation. It has a relatively fixed gestation of 145 days. The 
sheep model has been used to study the features of human placental insufficiency, and to 
evaluate therapeutic approaches to improve placental function(60).  
Important differences between the sheep and humans should be kept in mind. The sheep 
placenta is not haemochorial like that of the humans. In fact, there are multiple discrete 
cotyledons. Transfer of respiratory gases and nutrients in sheep is not directly from maternal 
blood as in humans, but through a lymph-like fluid. The fetal ductus arteriosus is longer than 
that in humans. Functionally, the ductus venosus delivers oxygenated blood from the umbilical 
vein to the formaen ovale in the sheep as well as humans. However, the anatomy is different. 
In the sheep fetus, the ductus venosus joins a relatively long thoracic segment of the inferior 
vena cava(14). A valvular membrane directs blood to foramen ovale in the sheep fetus. In the 
human fetus, there is no membrane, and thoracic part of the IVC is almost non-existent. The 
human fetus is less dependent on the laminar flow arrangement seen in the sheep fetus. The 
ductus venosus projects umbilical venous blood directly towards the foramen ovale(61).  
Rats and mice are easier and relatively inexpensive to maintain. The length of gestation for the 
mouse or rat pregnancies is short (20 and 21 days respectively). This limits the gestational age 
window in which to perform experiments. The pregnancies produce multiple litter. The size of 
each fetus is tiny, making both examination and instrumentation very difficult. The average 
heart rate of a mouse fetus is 500 BPM as opposed to 140 BPM in the sheep or human fetuses. 
It is possible that the mechanism of heart pumping is not directly comparable when the heart 
rates are so vastly differing. In pigs, the size of the mother is comparable to humans, but there 
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are multiple fetuses. Each fetus is small, and instrumentation is difficult. Although rhesus 
macaques(62) and baboons have been used in perinatal research, they are expensive to maintain.  
 
7.2 Experimental	models	of	fetal	Hypoxaemia	
There are several methods of creating hypoxaemia described in published literature, which 
suggests that no single one is ideal. Methods commonly described in the published literature 
are listed below. This is not an exhaustive list, but enumerates techniques commonly used by 
previous investigators in their publications.  
1. Reducing	the	partial	pressure	of	oxygen	in	air	inhaled	by	the	mother	–	This	can	
be	 achieved	 by	 attaching	 the	mother	 to	 a	 re-breathing	 circuit(20,	 62).	 This	 is	 an	 efficient	
method	 of	 creating	 acute	 fetal	 hypoxaemia,	 and	 is	 suitable	 for	 acute	 (short-term)	
experiments.	This	is	the	method	that	was	used	in	the	current	research.	The	advantages	of	this	
method	are	that	it	does	not	require	instrumentation	of	maternal	or	fetal	vessels,	and	loss	of	


















available	everywhere.	The	conditions	are	not	 similar	 to	 the	vast	proportion	of	human	and	
animal	pregnancies,	and	findings	are	not	directly	applicable	to	pathology.		





5. Embolising	 the	 placental	 circulation	 –	 In	 this	 technique,	 the	 fetus	 is	
instrumented.	Through	a	hysterotomy,	the	 lower	half	of	the	fetal	body	 is	exteriorised,	and	
catheters	are	placed	in	the	descending	aorta	through	the	fetal	femoral	artery.	Bolus	doses	of	




















investigating	 the	 effects	 of	 umbilical	 cord	 compression	 in	 labour.	 However,	 it	 is	 not	 an	
accurate	reflection	of	hypoxaemia	resulting	from	placental	dysfunction.		






8 Sildenafil and fetal cardiovascular physiology 
Sidenafil citrate (Sildenafil) has been developed for the treatment of erectile dysfunction(74). 
In normal pregnancy, the vasodilator nitric oxide contributes to the increased vasodilation and 
reduced vascular resistance seen in the uteroplacental circulation. The nitric oxide second 
messenger cGMP is enzymatically degraded by phosphodiesterases. Sildenafil, an inhibitor of 
phosphodiesterase-5 (PDE5), is able to enhance the vasodilatory action of nitric oxide(75). In-
vitro studies have shown that exposure to Sildenafil reduces contractility in the spiral arterioles. 
Wareing et al(76) showed in an in-vitro experiment that myometrial small artery function was 
abnormal in pregnancies affected with intrauterine growth restriction (IUGR), and incubation 
with Sildenafil citrate reversed the increase in contraction and significantly improved 
endothelial-dependent vasodilatation in arteries from pregnancies complicated by IUGR. 
Several studies are planned where Sildenafil will be used to improve placental function in 
human severe early onset IUGR with dismal prognosis(77). In a recent study in sheep, fetal 
growth restriction was induced by embolization of the uterine artery. The lamb and placental 
weights of Sildenafil treated fetuses of embolised ewes were comparable to the non-embolised 
ewes. Lamb and placental weights of embolised but untreated fetuses were significantly lower 
as compared to non-embolised controls. Thus, treatment with Sildenafil was associated with 
higher lamb and placental weights compared to those treated with vehicle(70). On the other 
hand, another study(68) reported significant fetal hypotension and tachycardia in response to 
Sildenafil. Sildenafil is usually administered to the mother in pregnancy. Maternal Sildenafil 
treatment may have effects on fetal physiology. Although the effects of Sildenafil on maternal 
physiology are studied well, there is relative paucity of information on the effects of Sildenafil 
on the fetus.  
 
8.1 Placental	transfer	of	Sildenafil	
The molecular structure of Sildenafil suggests that it should be able to cross the placenta. The 
work of Pellicer et al(78) demonstrates that this is actually true. These authors administered 4 
mg/kg/day of Sildenafil dissolved in the drinking water to pregnant rats. They found Sildenafil 
citrate (SC) and its metabolite desmethyl SC in the livers of fetal rats. The levels in the fetal 
liver correlated significantly with maternal serum levels of SC and desmethyl SC. This work 
shows that Sildenafil crosses the placental barrier at least in the rat. Rat placenta, like human 
placenta is haemochorial, in that fetally-derived trophoblast tissue is directly bathed in maternal 
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blood(79). The rodent (rat and mouse) placenta has three trophoblast layers between the 
maternal and fetal circulations. Therefore, placental transfer of Sildenafil is likely to be easier 
in the human placenta, where there is a single trophoblast layer between the maternal and fetal 
circulations(79). We were unable to find any published reports of measurements of Sildenafil 
levels in the fetal blood following maternal administration. Thus, the exact fraction of 
maternally administered Sildenafil reaching the fetus is currently uncertain.  
 
8.2 Is	there	substrate	for	Sildenafil	in	the	placenta	and	the	fetus?	
Maharaj(80) and co-workers examined this issue. They took samples of the second-order 
chorionic plate arteries from the placentas obtained after term vaginal or Caesarean delivery. 
RT-PCR in homogenised chorionic arteries demonstrated the presence of Phosphodiesterase-5 
mRNA. Western blotting and immunohistochemistry localised phosphodiesterase protein in 
chorionic plate arteries. They also investigated the effect of Sildenafil on chorionic arteries by 
attaching the vascular rings to a force transducer and exposing them to either Saline or 
Sildenafil. They showed a dose dependent relaxation of the chorionic arteries with Sildenafil in 
chorionic arteries pre-constricted with U46619, a Thromboxane analogue. The investigators 
were blinded to the presence of the active drug. This study shows that Phosphodiesterase is 
present in the chorionic arteries, and that it is sensitive to Sildenafil in a dose-dependent manner. 
These investigators also showed that Sildenafil significantly enhances the vasodilation 
produced by the NO donor sodium nitroprusside(80). This suggests that mechanism of action 
of Sildenafil involves increased responsiveness to nitric oxide.  
 
8.3 Sildenafil	and	teratogenesis	
Abott & co-workers(81) reviewed the safety profile of Sildenafil. They gave daily doses of 
Sildenafil, within and far beyond the human therapeutic range to dogs for up to one year and to 
rodents for up to two years. They reported very low risk of toxicity for Sildenafil.  Rats and 
rabbits were given high doses of Sildenafil (200 mg/kg/day) during organogenesis. No 
teratogenicity was observed(81). In comparison, the typical human dose is 1.43 mg/kg/day. 
This demonstrates excellent safety profile as far as teratogenesis of Sildenafil is concerned.  We 
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were unable to find any publications on the safety profile of a related compound Tadalafil, a 
longer acting PDE5 inhibitor(82).  
 
8.4 Effects	of	Sildenafil	on	fetal	heart	rate,	blood	pressure	and	feto-placental	circulation	
Work from adult medicine shows that Sildenafil has widespread effects on smooth muscles. In 
clinical practice it is used to relax the pulmonary vasculature in neonates(83) and adults(84) 
with pulmonary hypertension. Sildenafil is known to relax myometrial fibres(85). Placental 
transfer of Sildenafil may have effects on fetal physiology, as the smooth muscle relaxant 
properties are unlikely to be restricted only to maternal circulation. Virtually all tissues and cell 
types express PDE5(86). Miller & co-workers induced fetal growth restriction in six sheep 
fetuses by ligation of one of the two umbilical arteries, and compared them to controls at 0.7 
gestation. Both groups were given Sildenafil (intravenous bolus of 100 mg). They measured 
uterine blood flow before and after Sildenafil administration. Maternal administration of 
Sildenafil led to immediate reduction (-1h compared to 1h) in fetal mean arterial pressure in 
both groups(68). They also reported that there was no difference in the pre-treatment fetal heart 
rates, but Sildenafil administration was associated with an acute increase in fetal heart rate in 
both groups. Similar results (reduction in the blood pressure and increase in the heart rate) were 
seen with maternal parameters. It should be kept in mind that Miller and co-workers reported 
on the short-term effects of Sildenafil on fetal physiology. Proposed maternal administration of 
Sildenafil for maternal pulmonary hypertension or improvement in fetal growth by increase in 
the utero-placental blood flow is long-term. Therefore, the results of Miller et al may not be 
directly applicable where long-term administration of Sildenafil is being considered. Oyston & 
co-workers(70) also worked on the sheep model of IUGR, but did not report similar findings. 
They had 27 animals in three groups: controls, IUGR + Sildenafil and IUGR + vehicle. Their 
method of creating growth restriction was not the same as that reported by Miller et al. They 
induced IUGR was by embolisation of maternal uterine arteries. Sildenafil was administered to 
the mother by daily subcutaneous infusion of 150 mg over 12 hours using an infusion pump for 
21 days. They did not report on either maternal or fetal haemodynamic parameters. Therefore, 
the effect of Sildenafil on haemodynamic parameters of the mother or the fetus on slower 
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administration of Sildenafil in this study is unknown. However, they reported an improvement 
in the umbilical artery blood flow impedance and higher fetal weights with Sildenafil treatment.  
 
8.5 Effect	of	Sildenafil	on	fetal	pulmonary	circulation	
Sildenafil is clinically used to treat pulmonary hypertension in children and adults. Fetal 
pulmonary vasculature is known to be sensitive to the administration of Sildenafil. Sildenafil 
infusion to the fetus led to 60% reduction in pulmonary vascular resistance in normoxaemic 
fetuses in the chronically instrumented sheep model(87). The action of Sildenafil in 
hypoxaemic conditions is unknown. It may be possible to increase the left ventricular output 
by the administration of Sildenafil if Sildenafil could increase the pulmonary blood flow, and 




In the adult circulation, the left and the right ventricle are arranged in series. Therefore, by 
necessity, both pump the same volume of blood in a unit time. In the fetus, the ventricles are 
arranged in parallel. A sum of the output of both ventricles is referred to as the combined cardiac 
output (CCO). In the sheep model, combined cardiac output is 450 ml/min/Kg in the latter half 
of the pregnancy(14). The right ventricle ejects about 60-65%, and the left only 35-40% of 
CCO. The lungs receive 7-8% of CCO, and the remaining 55% of CCO ejected by the right 
ventricle passes through the ductus arteriosus(14). These measurements were obtained by the 
microsphere method or by electromagnetic flow transducers applied around the pulmonary 
trunk and ascending aorta. The placenta receives 40% of CCO in sheep (200 ml/min per kg 
fetal body weight).  
 
Invasive measurements are not possible in human pregnancies. However, ultrasound has been 
used to estimate cardiac outputs and flows to the placenta and lungs. In the human pregnancy 
the combined cardiac output is about 400 ml/min/Kg, and is almost unchanged from 18-41 
weeks (88). Normally, one third of the fetal combined cardiac output is distributed to the 
placenta in most of the second half of human pregnancy, and one fifth near term. In placental 
compromise this fraction is reduced while CCO/kg is maintained at normal levels, signifying 
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an increased recirculation of umbilical blood in the fetal body without being delivered to the 
placenta for oxygenation(88). Fetal pulmonary circulation is known to be increasingly 
responsive to blood oxygen levels with advancing gestation in the lamb(88). In normal human 
fetuses, the Doppler-measured impedance to flow in the peripheral pulmonary circulation 
decreases with advancing gestation(89). This decrease is seen till 30 weeks, and then remains 
stable(90). Human fetal pulmonary circulation has an important role in the distribution of the 
fetal cardiac output(90). The reactivity of the human fetal pulmonary circulation to maternal 
hyper-oxygenation increases with advancing gestation(89). This suggests that fetal pulmonary 
circulation is under acquired vasoconstriction at least after 31 to 36 weeks of gestation. 
Impedance to flow in the lungs is elevated in the presence of IUGR and this increase is related 
to the severity of fetal hypoxia(91). Presumably, the increase in the impedance to flow in the 
lungs is a compensatory mechanism for the presence of hypoxaemia seen with IUGR. Sildenafil 
is known to be pulmonary vasodilator. Therefore, fetal exposure to Sildenafil may change the 
distribution of the left and the right ventricular output, and interfere with this compensatory 
mechanism. There is insufficient information about fetal cardiac output of Sildenafil exposed 
fetuses. An alteration in the relative left and right ventricular outputs may be detrimental to the 
growth-restricted fetus. Future studies with Sildenafil use in pregnancy should collect 
information on the fetal left and right ventricular outputs.  
 
The target of Sildenafil (PDE5) is present in fetal and placental tissues. Short-term exposure to, 
or bolus administration of Sildenafil leads to a reduction in fetal mean arterial pressure, and a 
reduction in feto-placental blood flow(68). Fetal effects of long term administration on fetal 
cardiovascular parameters are unknown. There are no reports of detrimental effects of long-
term Sildenafil use on fetal growth. Future studies on Sildenafil administration to women during 





1. Increased placental vascular resistance with chronic hypoxaemia leads to an increase in 
fetal left ventricular MPI, and an acute reduction in fetal pO2 has a greater effect on left 
ventricular MPI in fetuses with increased placental resistance compared to control fetuses. 
2. Hypoxaemia is associated with a reduction in global myocardial deformation (measured 
by speckle tracking) and that the fetal left ventricle is more susceptible to the effect of 
hypoxaemia than the right ventricle.  
3. Sildenafil, a PDE inhibitor used to treat placental dysfunction, reverses pulmonary 
vasoconstriction resulting from hypoxaemia, increases the pulmonary venous return to the left 
atrium and increases left ventricular output.  





10 Aims and objectives 
The overarching objective of this thesis is to examine the effect of hypoxaemia on fetal cardiac 
function.  The specific aims are: 
1. To study the effect of both placental embolisation and maternal hypoxaemia on fetal 
left and right ventricular function as reflected by pulsed-wave Doppler derived myocardial 
performance index (MPI). 
2. To study myocardial systolic and diastolic function of the fetal left and right ventricles 
using ultrasound speckle tracking technique to measure global strain and strain rate. 
3. To examine if Sildenafil (Phospho-diesterase-5 inhibitor) can at least partially relieve 
reactive pulmonary vasoconstriction in a hypoxaemic fetus. This could improve pulmonary 
venous return to the left atrium and augment cerebral blood flow.  





This study was conducted in the Animal Laboratory of the University Hospital of Oulu, Finland. 
University Hospital Oulu has an established animal laboratory and active research program. 
The project leader has a long-standing collaboration with the University of Oulu and Oulu 
University Hospital, Oulu, Finland, and has been successfully performing animal experiments 
there for more than 14 years.  
 
11.1 Experimental	animal	model	
Time-dated pregnant sheep at 4/5th of the length of gestation (approximately day 115-129) 
were used for the study. The duration of sheep gestation is 145 days. 
 
11.2 Study	design	
Separate sets of experiments were performed for each component of the study described above. 
The experiments where the placenta was embolized had a separate control group with intact 
placenta for comparison. In other experiments, baseline measurements were performed before 
producing hypoxaemia by maternal hypo-oxygenation and each animal was its own control. 
Similarly, measurements were carried out in the recovery phase after the reversal of 
hypoxaemia, and evaluation of the fetal cardiac function was repeated. In fetuses exposed to 
Sildenafil, saline was used in the control group. 
 
11.3 Sample	size		
Experiments were designed in compliance with the 3-R principles (Reduction, Replacement 
and refinement) for using animals for experimental research.  We used the resource equation 
method to calculate the sample size(92). According to this method, a value “E” is measured, 
which is the degree of freedom of analysis of variance (ANOVA). The value of E should lie 
between 10 and 20(92). Any sample size, which keeps E between 10 and 20 should be 
considered as adequate. E can be calculated as follows: 
E = Total number of animals − Total number of groups 
For the first set of experiments there were four groups. Therefore, we included 12 animals in 
the intervention and 12 in the control group. For other two sets of experiments we had two 
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groups. Therefore, we used approximately 10-12 animals in each group. There were several 
phases of the experiment, and not all fetuses survived the entire experiment. The use of linear 
mixed model ensured that all the data were used, and no case was excluded from the analysis 
due to missing data.  
 
11.4 Research	Methods	
Details of the preparation of animal models have been documented in the published papers 
(Please refer to the appendix). All experiments took place at the animal laboratory of the 
University Hospital of Oulu (Figure 11-1) 
 
	
Figure 11-1 The animal laboratory of the university Hospital of Oulu 
 
In brief, the pregnant sheep of Finnish origin were operated under general endotracheal 
anaesthesia in order to place measurement equipment (arterial and venous catheters and flow 
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probes where appropriate) in the mother and the fetus. The animals were allowed to recover 
from the anaesthetic.  
 
	
Figure 11-2 Pregnant sheep recovering from the operation 
 
 
Experiments were performed after 4-5 days’ recovery. In the sub-set of animals where placental 
embolization was performed in order to increase placental vascular resistance and simulate 
placental insufficiency, this was carried out 24 hours before the experiments. Baseline 
assessment of fetal cardiac function was performed. Replacing oxygen by medical air in the 
maternal re-breathing circuit produced fetal hypoxaemia, and the assessment was repeated. Re-
instating oxygen reversed hypoxia, and a third set of assessment of fetal cardiac function was 
performed.  
In the first set of the experiments, we studied the effect of both placental embolisation and fetal 
hypoxaemia on fetal global cardiac function using pulsed-wave Doppler ultrasound. Left 
ventricular inflow and outflow Doppler velocity waveforms were recorded simultaneously and 
the myocardial performance index [(Left ventricular isovolumic contraction time + isovolumic 
relaxation time)/Ejection time] was measured. Fetal myocardial tissue was stored at -800C. 
Tissue was subjected to hypoxic gene panel using polymerase chain reaction (PCR) to assess 
expression of hypoxic genes. We measured the mRNA levels in the fetal heart by qRT-PCR of 
11 genes, representing various aspects of cardiac physiology: direct responses to hypoxia 
(HIF1a, angiopoietin 1), contractile function (troponin C, SERCA, phospholamban), metabolic 
function (carnitine palmitoyltransferase), endocrine function (ANP, BNP), neural regulation 
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(beta-1 adrenoreceptor, tachykinin) and cytokine regulation (signal transducer and activator of 
transcription 3, STAT3). 
In the second set of the experiments, we studied the changes in regional myocardial function of 
the fetal heart in response to hypoxaemia. Ultrasound speckle tracking, which is an angle 
independent technique for assessing myocardial function, was used for this purpose. A 
commercially available software (EchopacÒ) was used for the calculation of global strain and 
strain rates. The evaluation of strain and strain rate was performed off-line on stored loops of 
the ultrasound examinations carried out during the experiments. The measurements of global 
strain and strain rates were performed in duplicate in order to assess reproducibility.  
In the third set of the experiments, we compared the effect of fetal hypoxaemia on left and right 
ventricular cardiac function and its modification by administration of Sildenafil. In this 
experiment, pregnant sheep were operated under general anaesthetic for instrumentation of the 





An ultrasonic transit-time flow probe (Figure 11-3) was placed around the ductus arteriosus 
(Figure 11-4) to measure ductal blood flow.  
 
	





Figure 11-4 Specimen of the fetal heart in sheep shown after the end of the experiment 
A red rubber band is put around the ductus arteriosus. 
The ductus arteriosus was dissected (Figure 11-5) to allow placement of the flow probe around 






Figure 11-5 Ductus arteriosus is dissected in the fetal thorax following a thoracotomy. 
 
	
Figure 11-6 Ultrasonic transit time flow probe is secured around the ductus arteriosus 
 
The systolic function was evaluated using ventricular outputs, global longitudinal strain/strain 
rate with speckle tracking echocardiography and isovolumetric contraction velocities of the 
ventricular wall at the level of the mitral and tricuspid valves with tissue Doppler. Diastolic 
function was evaluated using isovolumetric relaxation velocities using tissue Doppler and 
pulsatility index of the ductus venosus with pulsed wave Doppler ultrasound. Pulmonary blood 
flow was calculated by subtracting the flow through the ductus arteriosus from right ventricular 
output. Pulsatility index of the right pulmonary artery was measured with pulsed wave Doppler 
ultrasound. The measurements were obtained at baseline, with hypoxaemia and at recovery in 
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fetuses receiving intravenous Sildenafil citrate and compared to those receiving intravenous 
saline infusion.  
 
11.5 Ethics	approval	
All these experiments are a part of an on-going project investigating fetal cardiovascular 
function in the chronically instrumented sheep model. The research protocol is approved by the 
National Animal Experiment Board in Finland (Approval no. ESAVI/1007/04.10.07/2014, 
Date of approval:13.03.2014, valid until 14.03.2017). The animal care and experimental 




Collected data were entered into a database, and checked for quality and completeness. Data 
analysis was performed using commercial statistical software (SPSS and SAS). Data 
distribution was tested for significant deviation from normality using Kolmogorov-Smirnoff 
test. To study differences between groups, independent sample student-t test was used for 
parametric and Mann-Whitney U test for nonparametric data. Paired t-test was used for 
longitudinal data with two states. Chi-square test or Fisher’s exact test were used to compare 
categorical data. Linear mixed model analysis was used to analyse data on repeated 
measurements taking into account correlation of measurements carried out in an individual 





12 Summary of results 
 
12.1 Paper	1	
In this experiment we evaluated global myocardial function with pulse-wave Doppler-based 
myocardial performance index. Placental vascular resistance and umbilical artery PI increased 
significantly with placental embolization. This was accompanied by significant fetal 
hypoxaemia. Fetal pH and base excess were no different. Left, right ventricular and combined 
cardiac outputs were comparable. Left and right ventricular MPI were no different at baseline.  
Attaching the mother to a re-breathing circuit led to significant reduction of fetal arterial pO2 
in both embolized and control groups. Fetal heart rate and ventricular outputs did not show 
significant changes. During hypoxaemia, mean LV MPI increased significantly only in fetuses 
with an intact placenta, returning to baseline during the recovery phase. Right ventricular MPI 
was unaffected. We also studied the expression of hypoxic genes in fetuses with and without 
placental embolisation. In general, expression of the hypoxaemic genes (HIF1a and ANGPT1) 
was no different with or without placental embolisation. Significantly lower expression of 
genes involved in cardiac contractile function (TNNC1 and ATP2A2), as well as its regulation 
(ADRB1) were seen in the group with placental embolisation. An explanation of the findings 
is that hypoxaemia leads to upregulation of cardiac genes in both groups, but less so with prior 
placental embolization. The ewes (and fetuses) were exposed to hypoxaemia for 15 minutes. It 
is possible that this period was too short to have an effect on the expression of hypoxic genes. 
Lower expression of genes involved with contractile function suggests that exposure to 
hypoxaemia has an effect on myocardial cellular calcium handling.   
We concluded that fetal left ventricle is more sensitive to acute hypoxaemia than the right 
ventricle. Exposure to chronic hypoxaemia could pre-condition the fetal heart and protect its 
function with worsening hypoxaemia. 
 
12.2 Paper	2	
In this manuscript we examine the effects of Hypoxaemia on fetal myocardial contractility 
using speckle tracking echocardiography. We hypothesized that in near-term sheep fetuses 
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hypoxaemia changes myocardial function that is reflected in altered ventricular deformation on 
speckle-tracking echocardiography.  
Baseline mean (SD) LV and RV global longitudinal strains were -18.7% (3.8) and -14.3% (5.3). 
Baseline RV global longitudinal and circumferential deformations were less compared to LV 
(p=0.016 and p<0.005). Although baseline right ventricular output is more than the left, 
baseline right ventricular global longitudinal and circumferential deformations are less 
compared to the left ventricle. LV, but not RV global longitudinal deformation reduces with 
Hypoxaemia compared to baseline. Circumferential and radial strains do not show significant 
changes.  
We concluded that, in near-term sheep fetus, LV global longitudinal and circumferential strains 
are more negative compared to RV. Acute hypoxaemia leads to LV rather than RV dysfunction 
as demonstrated by decreased deformation.  
 
12.3 Paper	3	
We examined the effect of acute hypoxaemia on fetal central cardiovascular parameters by a 
variety of indices, and its modification by administration of Sildenafil.  We tested the 
hypotheses that Sildenafil reverses pulmonary vasoconstriction resulting from hypoxaemia, 
increases left ventricular output by increasing pulmonary venous return and ameliorates 
myocardial dysfunction caused by hypoxaemia. We show that exposure to acute hypoxaemia 
influences fetal central cardiovascular function in the chronically instrumented fetal sheep 
model. We examined 24 pregnant sheep. Fetuses were made hypoxaemic and then given 
intravenous Sildenafil or saline infusion. Blood flow through ductus arteriosus was measured 
with an ultrasonic transit-time probe. Fetal cardiac function was examined using 
echocardiography.  
Fetal hypoxaemia led to pulmonary arterial vasoconstriction, decreased lung volume blood 
flow, increased shunting through the ductus arteriosus, and reduced left ventricular cardiac 
output. Mean arterial pressure and fetal pO2 were lower in the Sildenafil group at the end of the 
experiment. Sildenafil, when given directly to a hypoxaemic fetus, could not reverse this 
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redistribution of cardiac output. Furthermore, fetal cardiac systolic and diastolic dysfunction 







Fetal hypoxaemia is encountered commonly in fetal life. Fetal supply of oxygen from the 
mother is by diffusion, and not by active transport. Therefore, all fetuses are significantly 
hypoxaemic as compared to their mother. Further restriction of oxygen can be a challenge to 
the fetus, and there are several adaptive mechanisms. As mentioned previously, fetal and 
maternal placental blood flows and blood oxygen capacities can be altered by as much as 50% 
without any major change in fetal oxygen uptake(3). 
Fetal hypoxaemia can potentially result from reduced oxygen content of maternal blood 
(maternal anaemia, pregnancy at high altitude, maternal cyanotic heart disease), reduced rate 
of oxygen supply due to compromised utero-placental blood flow (maternal vascular disease 
such as pre-eclampsia), placental dysfunction (loss of placental villi), reduced fetal blood 
reaching the placenta for exchange (umbilical cord compression, typically intrapartum), 
reduced oxygenation of fetal blood (fetal anaemia) or reduced utilisation of the oxygen by the 
fetus (congenital fetal metabolic disorders).  Moreover, available oxygen may be insufficient 
due to high fetal demands (macrosomia/diabetic fetus). Detection of significant fetal 
hypoxaemia is important for the diagnosis of fetal compromise.  
In the current series of experiments, we assessed the fetal cardiovascular response to 
hypoxaemia in an experimental model of sheep pregnancy with the view to understand the 
pathophysiology. We used two methods to create acute and chronic hypoxaemia. Chronic 
hypoxaemia was created by embolisation of the placental circulation by placing catheters in the 
fetal descending aorta. Acute hypoxaemia was created by reducing the oxygen content of the 
air breathed by the ewe. Placental embolisation and creation of hypoxaemia mimics the 
pathophysiology of fetal growth restriction resulting from placental dysfunction. General 
anaesthesia is necessary to subject the animals to ultrasound examinations. Therefore, 
manipulation of oxygen inhaled by the mother is a convenient method to create fetal 
Hypoxaemia.  
Fetal MPI is known to reflect global myocardial function(43). It is also known to be a sensitive 
parameter of cardiac dysfunction(94, 95). MPI is elevated in fetuses affected with placental 
insufficiency(49). However, it is uncertain whether the change in MPI is a reflection of 
hypoxaemia, changes in cardiac loading conditions or a direct effect of myocardial cell damage. 
Placental vascular resistance is increased in fetuses with placental insufficiency, and can affect 
MPI due to increased afterload. In a previous report demonstrating increased left and right 
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ventricular MPI with hypoxaemia, umbilical cord occlusion was used to create 
hypoxaemia(50). We showed that left and right ventricular MPI was comparable in the two 
groups of fetus with and without increased placental vascular resistance, although fetuses with 
embolised placentas had significantly lower arterial pO2. Placentas were embolised at least 24 
hours before the experiment. MPI was measured using pulsed wave Doppler. Therefore, fetal 
myocardial function appears to adapt to increased placental vascular resistance and 
hypoxaemia. We further showed that acute hypoxaemia led to a significant increase in the left 
(but not right) ventricular MPI, but only in fetuses with intact placentas. LV MPI changes were 
not observed in the group of fetuses where the placental vascular resistance was already 
elevated by placental embolization. This shows that LV MPI changes may not be seen with 
significant further hypoxaemia in fetuses already compromised. We speculate that prior 
compromise by placental embolisation could pre-condition the fetal heart so that further 
hypoxaemia is tolerated without myocardial dysfunction. There is evidence in the literature for 
this pre-conditioning theory. 
Significant hypoxaemia leads to cellular injury and cellular death. Tissues respond to sub-lethal 
levels of hypoxaemia by upregulation of genes involved with cell survival. This hypoxaemia 
may be local or systemic. The ability of various tissue to withstand hypoxaemia is different. 
Therefore, significant hypoxaemia should be defined in relation to oxygen tension normally 
experienced by a cell type or tissue. hypoxia inducible factors play a central role in the ability 
of tissues/cells to withstand further episodes of hypoxaemia. Induction of HIF during repeated 
short episodes of ischaemia appears to provide resistance to a subsequent protracted ischaemic 
event(96). 
LV MPI appears to be a good test for acute rather than long-standing hypoxaemia. There is a 
modest overlap between the two groups of normoxaemic and hypoxaemic fetuses. Therefore, 
an absolute value is not particularly useful, and serial assessment have the advantage of each 
fetus acting as its own control.  
It has been shown in human fetuses that global longitudinal strain is similar in both ventricles 
at 20-24 weeks of gestation(97). Later in pregnancy LV global longitudinal strain does not 
change, however, corresponding RV strain or deformation decreases(98). This is explained by 
an increase in the RV preload. A reduction in the LV global longitudinal deformation with 
hypoxaemia may be a result of reduced LV preload, direct LV myocardial dysfunction or a 
combination of the two. It has been shown that pulmonary circulation is sensitive to fetal 
oxygenation during the last trimester of pregnancy(89), and that hypoxaemia leads to 
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pulmonary vasoconstriction(62). Indeed, in the current experiment RPA PI values increased 
significantly with hypoxaemia suggesting that impedance to pulmonary blood flow increased 
during hypoxaemia, although the reduction in the estimated pulmonary volume blood flow was 
not statistically significant. It has been shown in a near-term sheep model of acute ductus 
arteriosus occlusion that the fetus is unable to increase volume blood flow across the foramen 
ovale(99), thus the reduction in the LVCO is most likely a consequence of a drop in pulmonary 
volume blood flow leading to a decrease in LV preload. If the change in preload would be the 
major factor in the strain formation, we should have observed an opposite finding in the LV 
global longitudinal strain. Therefore, our results indicate that the direct effect of hypoxaemia 
on intrinsic contractile properties of the LV is likely responsible for decreased global 
longitudinal strain.  
 
13.1 Validity	of	the	results	
The sheep model has been extensively used for research in fetal hemodynamics. Guorang(50) 
et al reported on the effect of hypoxaemia with umbilical cord compression on the left and right 
ventricular MPI. The lowest fetal arterial pO2 reported by those authors in the cord occlusion 
group was 21.7 mm Hg (2.85 kPa). In contrast, the pO2 levels in the intact placenta group in 
our experiment were 2.3 kPa (17.5 mm Hg) and in the placental embolisation group was 1.2 
kPa (9.1 mm Hg). The decline in pO2 in the study of Guorong et al was 20% compared to 30% 
in the intact placenta fetuses and 38% in placental embolisation group in our study. The RV 
and LV MPI at baseline in the study by Guorong et al were 0.29 and 0.31 respectively, 
compared to 0.24 and 0.34 respectively, in our study. Although the LV MPI values in the two 
studies are very similar to each other, the RV MPI values are quite different. Right ventricular 
MPI needs to be calculated from separate cardiac cycles, because it is not possible to image the 
tricuspid and pulmonary valve simultaneously. Therefore, when pulsed wave Doppler is used, 
the accuracy of measurement is inferior for right ventricular MPI as compared to the left 
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ventricle. This is the most likely reason why the RV MPI values in the two studies are so 
dissimilar.  
Our results are in agreement with human fetal studies of placental insufficiency indicating 
comparable weight-indexed cardiac outputs for fetuses with normal placental hemodynamic 
findings(88).  
We used Sildenafil as an intravenous infusion to the fetus. Studies on the use of Sildenafil in 
placental insufficiency administer the drug to the mother over a period of days to weeks(70, 
100). Oyston et al, in a sheep model used continuous subcutaneous infusion to the ewe(70). 
Oral administration to the mother was used in humans(100).  There is published evidence 
showing fetal transfer of maternally administered Sildenafil(78). However, extrapolation of 
these results to human pregnancy should be done cautiously. The use of anaesthesia may have 
affected the results of the experiment. The experimental conditions are different from normal 
physiology, because the sheep and the fetus are under a general anaesthetic. Isoflurane can 
modify fetal cardiovascular regulation. However, newborn lambs under isoflurane anaesthesia 
are able to increase cardiovascular performance during stress(101). Previous work has shown 
that uterine and placental volume blood flows are comparable before and after general 
anaesthetic(34), suggesting unaltered cardiovascular response. Therefore, the results are likely 
to be close to physiologic conditions. 
Indexed cardiac output, baseline arterial pO2 and arterial pO2 following hypoxaemia are 




The surgical procedures may constitute a significant stress on the sheep fetuses, and it may be 
argued that the conditions are quite different from human fetuses exposed to hypoxaemia. 
Normal arterial blood gas values at the baseline stage suggest conditions close to physiologic 
circulatory state(34). The study was carried out in a narrow gestational age window of 115-129 
days, and may limit the validity and significance outside this time period. Extrapolation of these 
results to human pregnancy should be done cautiously. The sheep model has been extensively 
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used for research in fetal hemodynamics, and the myocardial strain curves are similar in normal 
ovine and human pregnancy. 
We wished to assess the effect of fetal hypoxia caused by reducing the oxygen delivered to the 
mother on duration of events in the cardiac cycle. This has obvious implications on developing 
more sensitive tests for subtle cardiac dysfunction resulting from fetal hypoxia. Use of animal 
model allowed us to measure (and control) fetal oxygenation using invasive monitoring. It 
could be argued that the reduction in LV global longitudinal strain could just reflect a drop in 
cerebral vascular resistance during hypoxaemia. Hypoxaemia leads to pulmonary 
vasoconstriction, reduction in pulmonary volume blood flow and therefore less pulmonary 
venous return to the left atrium. The capacity to increase shunting across foramen ovale to 
compensate reduced left atrial filling is limited(103, 104). So, hypoxaemia could reduce left 
ventricular output by reduced pre-load. We did not monitor cerebral blood flow during the 
experiment. This is because the vascular catheters were placed in the left carotid artery and the 
left jugular vein of the fetus to measure fetal blood pressure and obtain blood gases and the 
presence of the catheter in the carotid artery would mean that measurements changes in MCA 
PI would be unreliable and difficult to interpret.  However, we measured the fetal blood pressure 
from the carotid artery, which is a direct reflection of left ventricular afterload.  
Analysis of the ultrasound images was performed by examiners blinded to the allocation. 
Therefore, it is unlikely to result in a bias. All volume flow measurements were indexed to fetal 
weight, eliminating the effect of the size of the fetus. The surgical procedures may constitute a 
significant stress on the sheep fetuses, and it may be argued that the conditions are quite 
different from human fetuses exposed to hypoxaemia. Normal arterial blood gas values at the 
baseline stage suggest conditions close to physiologic circulatory state. Availability of invasive 
data and oxygenation lend important validation to the results. This is usually impossible in 






1. Placental	 vascular	 resistance	 and	 umbilical	 artery	 PI	 increase	 significantly	 with	
placental	embolization.	This	is	accompanied	by	significant	fetal	hypoxaemia.	Fetal	pH	
and	 base	 excess	 as	 well	 left,	 right	 and	 combined	 ventricular	 cardiac	 outputs	 are	
maintained.	









6. Acute	 hypoxaemia	 is	 associated	 with	 pulmonary	 vasoconstriction,	 and	 increased	
shunting	through	the	ductus	arteriosus.	It	is	also	associated	with	reduced	myocardial	
deformation	as	well	as	reduced	isovolumetric	contraction	and	relaxation	velocities.	
7. Sildenafil	 does	 not	 alter	 the	 fetal	 pulmonary	 vasoconstriction	 in	 response	 to	
hypoxaemia.	Sildenafil	does	not	alter	the	parameters	of	myocardial	function.	





15 Future perspectives 
Addition of biomarkers to ultrasound evaluation may improve the assessment of response of 
the fetal heart function to hypoxaemia. Myocardial global longitudinal strain measurements for 
clinical use in suspected hypoxaemia in human pregnancies need validation studies. Future 
studies on the use of Sildenafil will benefit by the results of this study that pulmonary blood 
flow is unaffected by the intervention. The potentially detrimental finding that fetuses exposed 
to Sildenafil had a lower arterial pO2 in the recovery phase needs further investigation. Future 
studies should include the assessment of fetal cerebral blood flow to make sure that the adaptive 
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17 Supplementary tables 
17.1 Primers	and	bifunctional	probes	(5’-FAM,	3’-TAMRA)	used	in	the	qRT-PCR	reactions.		
The sequences are listed in the 5’ to 3’ direction. (Supplementary table in Paper I).  
 
Gene Forward primer Reverse primer Probe 
ADRB1 AGACGCTCACCAACCTCTTCA GGCACTACCAGCAGACCCA CTGGCCAGCGCAGACCTGGT 
ANGPT1 GCAAATGTGCCCTCATGCT TCCATTTAGATTGGATGGGCC ACAGGAGGCTGGTGGTTTGATGCC 
ATP2a2 TGCTCTTTTCTGGCACAAACA TAACGCCAGTTGCCACCAC TGCTGCTGGCAAAGCCATGGG 
CPT1A CCAGTTCACAGTCACCCCG GATCTGCCTGAGGGCCTCA ATGGCATCGACCTCCGAATGAGCC 
HIF1A CATGCCCCAGATTCAAGATCA TGGGACTGTTAGGCTCAGGTG CCAGCTAGTCCTTCTGATGGAAGCACCA 
NPPA TTCCTCCTCTTTGTGGCGTT CACAGAGCCATACACGGGATT CAGCTCCCAGGGCAAACAGGAGC 
NPPB GACCCCCAGAAGGCGC TAGCAGCGACAGGTGCAAGA TCCCGAACGCTCCTGCTTCTCCT 
PLN AATACTATATAAGAGACCACTTCCTAAATAGAAGAA GCAGATGAATACGTTTGCTAACAATT TTTGTGAAAAGGTCGAGATTTGGAACAGAGC 
STAT3 ATCGACCTGGAGACGCACTC AGGCGTTGGGCATCTGAC TTGCCAGTGGTGGTGATCTCCAACA 
TAC1 GCCCTTTGAGCATCTTCTGC GCCCATCAATCCAAAGAACTG ATCGCTCGGAGACCCAAGCCTCA 


















































Figure 18-5 Weight indexed umbilical artery volume blood flow with hypoxaemia and 
placental embolisation  
Solid line: Intact placenta, Broken line: Placental embolization. Significant difference 
between fetuses with intact placenta versus those with placental embolisation (p=0.009). No 
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